🇺🇸 Caltrate in United States

9,804 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 9,804

Most-reported reactions

1. Fatigue — 1,381 reports (14.09%)
2. Nausea — 1,187 reports (12.11%)
3. Diarrhoea — 1,169 reports (11.92%)
4. Pain — 916 reports (9.34%)
5. Drug Ineffective — 868 reports (8.85%)
6. Fall — 868 reports (8.85%)
7. Arthralgia — 865 reports (8.82%)
8. Dyspnoea — 857 reports (8.74%)
9. Dizziness — 848 reports (8.65%)
10. Headache — 845 reports (8.62%)

Source database →

Frequently asked questions

Is Caltrate approved in United States?

Caltrate does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Caltrate in United States?

Second Affiliated Hospital of Wenzhou Medical University is the originator. The local marketing authorisation holder may differ — check the official source linked above.